NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 1.630
+0.020 (1.24%)
At close: Aug 26, 2026
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of €186.18 million as of August 26, 2026. Its market cap has decreased by -62.74% in one year.
Market Cap
186.18M
Enterprise Value
26.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.63
ChartMarket Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from 124.45M to 186.18M, an increase of 49.60%. That is a compound annual growth rate of 6.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 191.84M | -50.91% |
| Dec 31, 2025 | 390.81M | 484.53% |
| Dec 31, 2024 | 66.86M | -53.13% |
| Dec 29, 2023 | 142.66M | -56.11% |
| Dec 30, 2022 | 325.02M | -89.87% |
| Dec 31, 2021 | 3.21B | 18.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 69.60M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.45M |
| Vidac Pharma Holding | 21.53M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 231.09K |